Author

P. Priestley

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Assay:whole-genome sequencing· 4 Approach:experimental assay· 3 Research Focus:variant calling· 3 Research Focus:variant effect prediction· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:deep learning· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

E. Cuppen· 4 shared C. Shale· 3 shared A. van Hoeck· 2 shared E. Kuijk· 2 shared J. Baber· 2 shared N. Besselink· 2 shared A. Borgman· 1 shared A. T. Papenfuss· 1 shared

Activity by Year

2019-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

E. Cuppen

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Recurrent exon-deleting activating mutations in AHR act as drivers of urinary tract cancer

J. Vlaar, A. Borgman, E. Kalkhoven, D. Westland, N. Besselink, C. Shale, B. M. Faltas, P. Priestley, E. Kuijk, E. Cuppen

This study identifies AHR{Delta}e8-9 as a novel driver mutation in urinary tract cancer, leading to ligand-independent pathway activation and tumorigenic properties in bladder organoids.

bioRxiv · Nov 9, 2021Cancer Biology

Unscrambling cancer genomes via integrated analysis of structural variation and copy number

C. Shale, J. Baber, D. Cameron, M. Wong, M. J. Cowley, A. T. Papenfuss, E. Cuppen, P. Priestley

This paper introduces LINX, a tool for analyzing structural variation and copy number alterations in cancer genomes, revealing novel insights into oncogenic fusions and inactivation events.

bioRxiv · Dec 3, 2020Cancer Biology

Pan-cancer whole genome analyses of metastatic solid tumors

P. Priestley, J. Baber, M. Lolkema, N. Steeghs, E. de Bruijn, K. Duyvesteyn, S. Haidari, A. van Hoeck, W. Onstenk, P. Roepman, C. Shale, M. Voda, H. Bloemendal, V. Tjan-Heijnen, C. van Herpen, , E. Cuppen

This study analyzes whole genome sequences of metastatic solid tumors to identify genetic variants that may influence treatment outcomes.

bioRxiv · Aug 12, 2019 · PreprintCancer Biology

5-Fluorouracil treatment induces characteristic T>G mutations in human cancer

S. Christensen, B. vd Roest, N. Besselink, R. Janssen, S. Boymans, J. Martens, M.-L. Yaspo, P. Priestley, Center for Personalized Cancer Treatment, E. Kuijk, E. Cuppen, A. van Hoeck

This study shows that 5-FU treatment causes characteristic T>G mutations in cancer, similar to endogenous mutational signatures, and may increase secondary malignancy risk.

bioRxiv · Jun 25, 2019Cancer Biology